Chondroitin sulfate

Arthage emulgel is indicated for the treatment of degenerative-dystrophic diseases of the joints and spine (mainly localized forms): osteoarthritis, osteochondrosis.

Structure

Active ingredient: chondroitin sodium sulfate;

1 g of Emulgel contains chondroitin sodium sulfate (in terms of 100% dry matter) - 50 mg;

Excipients: imidourea, dimethyl sulfoxide, propylene glycol, polyethylene glycol (macrogol) cetostearyl ether, cocoyl caprylocaprate, cetostearyl alcohol, hydroxypropyl starch phosphate, citric acid monohydrate, sodium citrate, dimethicone, purified water.

Contraindications

Thrombophlebitis, individual hypersensitivity to the components of the drug, a tendency to bleeding, acute inflammatory processes in the area of ​​application of the drug.

Mode of application

Emulgel is applied 2-3 times a day with a thin layer on the skin in the affected area, easily rubbing until completely absorbed. The duration of the course of treatment is determined individually depending on the effectiveness and tolerability of therapy, and, as a rule, is 2-3 weeks.

Application features

Pregnant women

Safety and efficacy have not been established, therefore, the drug can only be used if, in the opinion of the doctor, the benefits of the application outweigh the risk.

Children

Not applicable.

Drivers

Does not affect.

Overdose

Cases of drug overdose are not described. Subject to recommendations for use, an overdose of the drug is unlikely.

Side effects

The drug is usually well tolerated, but skin irritation, allergic reactions, including itching, hyperemia, burning, rashes on the skin are possible, which requires discontinuation of the drug.

Interaction

With external use of the drug, its interaction with other drugs has not been established.

Storage conditions

Store in the original packaging at a temperature not exceeding 25 ° C. Do not freeze.

Keep out of the reach of children.

Shelf life is 2 years.